Chlorambucil
Back to searchMolecule Structure
Scientific Name
Chlorambucil
Description of the Drug
Chlorambucil is a chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00291
http://www.drugbank.ca/drugs/DB00291
Brand Name(s)
Leukeran
Company Owner(s)
Woodward Specialty Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4308 | ||||
| PharmGKB | PA448926 | ||||
| Human Metabolome Database | HMDB0014436 | ||||
| DrugBank | DB00291 | ||||
| PubChem: Thomson Pharma | 14825408 | ||||
| PubChem | 2708 | ||||
| Mcule | MCULE-2575006904 | ||||
| LINCS | LSM-2645 | ||||
| Nikkaji | J1.521K | ||||
| PDBe | CBL | ||||
| BindingDB | 50003677 | ||||
| EPA CompTox Dashboard | DTXSID7020263 | ||||
| DrugCentral | 588 | ||||
| Brenda | 6964 | 229264 | 229263 | 229299 | 229300 |
| ChemicalBook | CB5270716 | ||||
| Guide to Pharmacology | 7143 | ||||
| rxnorm | CHLORAMBUCIL | LEUKERAN | |||
| PubChem: Drugs of the Future | 99431548 | ||||
| KEGG Ligand | C06900 | ||||
| ChEBI | 28830 | ||||
| ZINC | ZINC000000001115 |
